Acta Scientific Cancer Biology (ASCB)

Editorial Volume 8 Issue 3

The Main Advances in Oncology in 2023, What Awaits us by 2024?

Adrian P Hunis*

Department of Cancer Biology, Argentina

*Corresponding Author: Adrian P Hunis, Department of Cancer Biology, Argentina.

Received: January 17, 2024; Published: February 01, 2024

Reprints View PDF Related Articles

×

As we begin a new year, 2024, let's take a look back at the advancements in oncology in 2023. The year 2023 witnessed significant progress in the field of cancer research and treatment. Here are some notable achievements.

×

References

×

Citation

Citation: Adrian P Hunis. “The Main Advances in Oncology in 2023, What Awaits us by 2024?”.Acta Scientific Cancer Biology 8.3 (2024): 01-02.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.